RethinkPeptides
ArticlesTopicsResearch

GLP-1 and Addiction

3 articles in this topic.

GLP-1 and Addiction

Semaglutide and Alcohol: Why Ozempic Reduces Drinking

Clinical trial and real-world data show semaglutide reduces alcohol intake and cravings. How GLP-1 receptors in the brain's reward system explain the effect.

13 min read|Mar 25, 2026
GLP-1 and Addiction

GLP-1 Agonists and Compulsive Behavior

GLP-1 receptor agonists reduce compulsive behaviors beyond appetite, from alcohol to gambling. Eight studies reveal how they reshape the brain's reward system.

14 min read|Mar 22, 2026
GLP-1 and Addiction

Could GLP-1 Drugs Treat Addiction? The Early Evidence

Can semaglutide and other GLP-1 drugs treat addiction? We review clinical trials and preclinical evidence for alcohol, cocaine, opioids, and nicotine.

14 min read|Mar 21, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.